Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Czechia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20091
20103
20112
20121
20132
20162
20171
20191
20202
20212
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
AstraZeneca4
Chiesi Farmaceutici S.p.A.2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
Eli Lilly and Company1
Genentech, Inc.1
GlaxoSmithKline1
Ionis Pharmaceuticals, Inc.1
MedImmune LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive24
Bronchitis, Chronic4
Emphysema4
Bronchiolitis Obliterans Syndrome3
Bronchitis2
Lung Diseases2
Amyotrophic Lateral Sclerosis1
Inflammation1
Lung Diseases, Obstructive1
Major Depressive Disorder1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.